Callan Family Office LLC Boosts Position in Relx Plc $RELX

Key Points

• Callan Family Office LLC increased its stake in Relx Plc by 263.0% during the second quarter, acquiring a total of 33,716 shares valued at approximately $1.8 million.
• The firm announced a recent semi-annual dividend cut, with a payout of $0.2634 per share, leading to a yield of 170.0% and a dividend payout ratio of 28.49%.
• Several analysts have recently issued mixed ratings for Relx, with Barclays and Morgan Stanley maintaining an "overweight" rating, while Wall Street Zen downgraded it from "buy" to "hold."

Callan Family Office LLC boosted its position in shares of Relx Plc (NYSE:RELX - Free Report) by 263.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 33,716 shares of the technology company's stock after acquiring an additional 24,429 shares during the quarter. Callan Family Office LLC's holdings in Relx were worth $1,832,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Dempze Nancy E increased its position in Relx by 7.5% during the second quarter. Dempze Nancy E now owns 5,315 shares of the technology company's stock valued at $289,000 after acquiring an additional 370 shares during the last quarter. Narwhal Capital Management bought a new stake in Relx during the second quarter valued at about $6,788,000. Puzo Michael J grew its holdings in Relx by 3.9% during the second quarter. Puzo Michael J now owns 10,748 shares of the technology company's stock valued at $584,000 after purchasing an additional 405 shares during the period. Triasima Portfolio Management inc. grew its holdings in Relx by 192.2% during the second quarter. Triasima Portfolio Management inc. now owns 127,720 shares of the technology company's stock valued at $6,940,000 after purchasing an additional 84,010 shares during the period. Finally, Venturi Wealth Management LLC grew its holdings in Relx by 1.0% during the second quarter. Venturi Wealth Management LLC now owns 24,476 shares of the technology company's stock valued at $1,330,000 after purchasing an additional 232 shares during the period. Hedge funds and other institutional investors own 15.02% of the company's stock.

Relx Stock Performance

NYSE:RELX opened at $44.80 on Friday. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55. Relx Plc has a 12-month low of $44.19 and a 12-month high of $56.33. The stock has a 50-day moving average price of $47.22 and a 200 day moving average price of $50.81. The stock has a market capitalization of $81.87 billion, a P/E ratio of 24.08, a P/E/G ratio of 2.92 and a beta of 0.87.

Relx Cuts Dividend

The firm also recently announced a semi-annual dividend, which was paid on Tuesday, September 16th. Investors of record on Friday, August 8th were given a dividend of $0.2634 per share. The ex-dividend date was Friday, August 8th. This represents a dividend yield of 170.0%. Relx's dividend payout ratio (DPR) is currently 28.49%.

Analysts Set New Price Targets

Several analysts have issued reports on RELX shares. Barclays reissued an "overweight" rating on shares of Relx in a report on Tuesday. Kepler Capital Markets raised Relx from a "hold" rating to a "strong-buy" rating in a report on Thursday, September 18th. Morgan Stanley reissued an "overweight" rating on shares of Relx in a report on Thursday, September 11th. Weiss Ratings reissued a "buy (b)" rating on shares of Relx in a report on Wednesday. Finally, Wall Street Zen lowered Relx from a "buy" rating to a "hold" rating in a report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.